Outlook of SNCA (alpha-synuclein) transgenic fly models in delineating the sequel of mitochondrial dysfunction in Parkinson's disease. Samson JS, Rajagopal K, Parvathi VD. Brain Res 2025;1852:149505.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Samson JS, Rajagopal K, Parvathi VD. Outlook of SNCA (alpha-synuclein) transgenic fly models in delineating the sequel of mitochondrial dysfunction in Parkinson's disease. Brain Res 2025;1852:149505.
PMID: 39954798